SPY299.08+3.64 1.23%
DIA250.25+5.37 2.19%
IXIC9,340.22+15.63 0.17%

Stifel Maintains Buy on Cue Biopharma, Raises Price Target to $30

Stifel maintains Cue Biopharma (NASDAQ:CUE) with a Buy and raises the price target from $25 to $30.

Benzinga · 05/20/2020 13:34

Stifel maintains Cue Biopharma (NASDAQ:CUE) with a Buy and raises the price target from $25 to $30.